Global Engagement Across Australia and Singapore Strengthens Strategic Partnerships
Brisbane, Australia – December 9, 2026 – A recent international engagement tour spanning five cities across Australia and Singapore marked a significant period of strategic meetings, industry collaboration, and ecosystem building for Ketim Technologies.
Dr. Clarissa Yates and Co-Founder Dr. Maciej Trzaskowski travelled through Melbourne and Sydney for AusBiotech and partner meetings before continuing to Singapore for Singapore Week of Innovation and Technology (SWITCH).
Across 11 days, the team engaged with research collaborators, government representatives, industry leaders, and international biotech partners to advance discussions around biomarker validation, commercial pathways, and global market access.
Key conversations included ongoing collaboration with AGRF Ltd, engagement with the Department of Industry, Science and Resources’ IGP cohort, and discussions with emerging diagnostics and health technology partners in both Australia and Singapore. “This trip reinforced the importance of international collaboration in bringing precision psychiatry into clinical practice,” said Dr. Yates. “Translating biomarker science into global health solutions requires strong partnerships across research, government, and industry.”
The visit reflects Ketim’s growing international footprint as the company advances development of its predictive protein blood test for postpartum depression and builds pathways toward global commercialisation.
For media inquiries, please contact:
Dr. Clarissa Yates
CEO, Ketim Technologies
clarissa.yates@ketim.com.au
